Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Role of valsartan, amlodipine and hydrochlorothiazide fixed combination in blood pressure control: an update.

Destro M, Cagnoni F, D'Ospina A, Ricci AR, Demichele E, Peros E, Zaninelli A, Preti P.

Vasc Health Risk Manag. 2010 Apr 15;6:253-60.

2.

Comparison between metalloproteinases-2 and -9 in healthy subjects, diabetics, and subjects with acute coronary syndrome.

Derosa G, D'Angelo A, Scalise F, Avanzini MA, Tinelli C, Peros E, Fogari E, Cicero AF.

Heart Vessels. 2007 Nov;22(6):361-70. Epub 2007 Nov 26.

PMID:
18043992
3.

Metalloproteinases in diabetics and nondiabetics during acute coronary syndromes and after 3 months.

Derosa G, Cicero AF, Scalise F, Avanzini MA, Tinelli C, Peros E, Fogari E, D'Angelo A.

Endothelium. 2007 Jul-Oct;14(4-5):175-83.

PMID:
17922333
4.

Metalloproteinase-2 and -9 in diabetic and nondiabetic subjects during acute coronary syndromes.

Derosa G, Cicero AF, Scalise F, Avanzini MA, Tinelli C, Piccinni MN, Peros E, Geroldi D, Fogari E, D'Angelo A.

Endothelium. 2007 Jan-Feb;14(1):45-51.

PMID:
17364896
5.

Elevated plasma levels of lipoprotein(a) in psychiatric patients: a possible contribution to increased vascular risk.

Emanuele E, Carlin MV, D'Angelo A, Peros E, Barale F, Geroldi D, Politi P.

Eur Psychiatry. 2006 Mar;21(2):129-33.

PMID:
16516110
6.

Antithrombotic effects of rosiglitazone-metformin versus glimepiride-metformin combination therapy in patients with type 2 diabetes mellitus and metabolic syndrome.

Derosa G, Gaddi AV, Piccinni MN, Ciccarelli L, Salvadeo S, Peros E, Ghelfi M, Ferrari I, Cicero AF.

Pharmacotherapy. 2005 May;25(5):637-45.

PMID:
15899724
7.

Analysis of the apolipoprotein(a) size polymorphism in patients with systemic lupus erythematosus.

Peros E, Geroldi D, Bugatti S, Caporali R, Rossi P, Montecucco C, D'Angelo A, Emanuele E.

Int J Mol Med. 2005 Apr;15(4):661-5.

PMID:
15754029
8.

Apolipoprotein(a) size polymorphism is associated with coronary heart disease in polygenic hypercholesterolemia.

Emanuele E, Peros E, Minoretti P, D'Angelo A, Piccinni MN, Montagna L, Geroldi D.

Nutr Metab Cardiovasc Dis. 2004 Aug;14(4):193-9.

PMID:
15553596
9.

Significance of apolipoprotein(a) phenotypes in acute coronary syndromes: relation with clinical presentation.

Emanuele E, Peros E, Minoretti P, D'Angelo A, Montagna L, Falcone C, Geroldi D.

Clin Chim Acta. 2004 Dec;350(1-2):159-65.

PMID:
15530473
10.

Association between low-molecular weight apolipoprotein(a) isoforms and obesity in Italian women.

Derosa G, Fogari R, Piccinni MN, Peros E, Bertone G, Ciccarelli L, Tinelli C, Geroldi D, Pannacciulli N, De Pergola G.

Obes Res. 2004 Aug;12(8):1322-6.

11.

Relation of apolipoprotein(a) size to alzheimer's disease and vascular dementia.

Emanuele E, Peros E, Tomaino C, Feudatari E, Bernardi L, Binetti G, Maletta R, Micieli G, Bruni AC, Geroldi D.

Dement Geriatr Cogn Disord. 2004;18(2):189-96. Epub 2004 Jun 21.

PMID:
15211075
12.

Plasma osteoprotegerin as a biochemical marker for vascular dementia and Alzheimer's disease.

Emanuele E, Peros E, Scioli GA, D'Angelo A, Olivieri C, Montagna L, Geroldi D.

Int J Mol Med. 2004 Jun;13(6):849-53.

PMID:
15138623
13.

Apolipoprotein(a) null phenotype is related to a delayed age at onset of Alzheimer's disease.

Emanuele E, Peros E, Tomaino C, Feudatari E, Bernardi L, Binetti G, Maletta R, D'Angelo A, Montagna L, Bruni AC, Geroldi D.

Neurosci Lett. 2004 Feb 26;357(1):45-8.

PMID:
15036610
14.

Lipoprotein(a)-associated atherothrombotic risk in hemodialysis patients.

Emanuele E, Lusignani LS, Peros E, Montagna G, D'Angelo A, Montagna L, Geroldi D.

Am J Nephrol. 2004 Mar-Apr;24(2):221-9. Epub 2004 Mar 12.

PMID:
15017119
15.

Apolipoprotein(a) phenotypes are reliable biomarkers for familial aggregation of coronary heart disease.

Peros E, Geroldi D, D'Angelo A, Falcone C, Montagna L, Carabela M, Emanuele E.

Int J Mol Med. 2004 Feb;13(2):243-7.

PMID:
14719130
16.

Relationship between apolipoprotein(a) size polymorphism and coronary heart disease in overweight subjects.

Emanuele E, Peros E, Minoretti P, Falcone C, D'Angelo A, Montagna L, Geroldi D.

BMC Cardiovasc Disord. 2003 Dec 12;3:12.

17.

Association between small apolipoprotein(a) isoforms and frontotemporal dementia in humans.

Emanuele E, Peros E, Tomaino C, Feudatari E, Bernardi L, Binetti G, Maletta R, Micieli G, Bruni AC, Geroldi D.

Neurosci Lett. 2003 Dec 26;353(3):201-4.

PMID:
14665416

Supplemental Content

Support Center